Sirtris Pharmacueticals reported today that one of its new chemical entities, which is 1,000 times more potent than resveratrol, reduces fat, boosts exercise endurance and improves insulin sensitivity in mice on a high-fat diet. Aside from the diabetes potential of the NCE, Sirtuin Investor wonders: Could SIRT's NCE, at some point, could become the next performance enhancing drug to hit the sports world? Only unlike, steroids it may have a safe profile without steroid side effects. Time will tell.
Nonetheless, while preliminary with regard to human trials, this is certainly good news for SIRT and they will present the data this Saturday at the Keystone Symposia on Diabetes Mellitus, Insulin Action and Resistance Conference.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment